Tulsa Cancer Institute, Pllc
12697 E 51st Street South
Tulsa, Oklahoma 74146
918-505-3200 http://www.tciok.org

Use our guide to learn which trials are right for you!

Now under the new name of Tulsa Cancer Institute, our specialists have been providing cancer care services to Oklahomans since 1972. Tulsa Cancer Institute is a physician-owned group practice with 23 blood and cancer specialists and more than 200 nurses and associates in northeastern Oklahoma. This specialty medical practice provides superior multidisciplinary care for patients with cancer and other blood disorders. We remain active in clinical research trials, strive to implement the latest technologies, and provide a continuum of care and support with our patients' best interest in mind. We boast some of the best cancer specialists in the region and offer a customized care plan for each and every patient. We focus on recovery and a long and healthy future for our patients.

As we march into our 41st year in the fight against cancer, we are improving our organization with new physicians and specialties, new technologies and new facilities while maintaining our mission for our patients and their families, providing information, hope, comfort and treatment. We are proud to continue basing our specialty group practice on clinical excellence, customer service, mutual respect, stewardship of medical resources, and scientific discovery.

We've found
5 trials
at this facility
Oncology, Reproductive Clinical Trial
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Status: Enrolling
Updated: 3/7/2014
mi
from
Tulsa, OK
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
mi
from
Tulsa, OK
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tulsa, OK
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tulsa, OK
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Status: Enrolling
Updated: 4/4/2013
mi
from
Tulsa, OK
Click here to add this to my saved trials